Amarin Corp Plc (AMRN)

[The Irishman]

Greymatter1:

Your thought:
“It is obvious now that the CAFC for whatever reason will not find in favor of AMRN. AMRN will abandon all promotion and marketing in the US and move to launch their own generic. Patients in need will suffer.
Any buyout/sale of the company is unlikely but if it happens it will be for a fraction of what it could have been without the US market. “

What makes you say that the court of appeals will not find for Amarin? You use the word “obvious “.
I don’t want to assume anything. So I will ask a couple of questions.
1. Is your statement based on the ANDA approval?
2. Do you have some information that we are not aware of?

Regarding the first question, I will offer this. The generic approval and the FDA’s work to accomplish that has nothing to do with what’s happening in the Federal court of appeals. To say that this was most unexpected would be fooling ourselves. We all should have factored this in. If we didn’t, then are we truly informed investors?
Approval doesn’t mean launch. However, we should plan for them to launch.
It’s up to Amarin to obtain the injunction. I’m sure that plan was baked already.
Last point: The FDA did their job. We don’t agree with it, yet they had two drug applications on the table to approve or deny. If the submissions met the burden, then they proceeded. The ball is in Amarin’s court now. Stay tuned...